| 摘要 |
The present invention relates to a new method of adjuvant therapy in the treatment of metastatic breast or ovarian cancer, comprising administering six cycles of docetaxel, doxorubicin and cyclophosphamide to a patient in need thereof, wherein said dosages have a marked therapeutic effect when compared to other adjuvant therapies. |
